EPIDEMIOLOGICAL CHARACTERISTICS OF METABOLIC RISK FACTORS FOR GASTRODUODENAL ULCERS IN THE POPULATION OF LONG-LIVERS
DOI:
https://doi.org/10.55640/Keywords:
xAbstract
x
Downloads
References
1.Ivashkin V.T., Maev I.V., Lapina T.P., Sheptulin A.A., et al. Clinical guidelines of the Russian Gastroenterological Association on the diagnosis and treatment of Helicobacter pylori infection in adults. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018; 28(1): 55–70.
2.Karasheev A.E., Nasonova V.A. Development and recurrence of gastric and duodenal ulcers in patients receiving non-steroidal anti-inflammatory drugs: the impact of standard risk factors. Therapeutic Archive. 2008; (5): 63–65.
3.Kerimov M.K., Kakhanenko N.Yu., Lugovoy A.L., Danilov S.A., Serikov V.A. Endovideosurgery in the treatment of patients with perforated gastro-duodenal ulcers. Medicine: Theory and Practice. 2018; 3: 3–8.
4.Clinical guidelines: use of NSAIDs. Association of Rheumatologists of Russia, Scientific Society of Gastroenterologists of Russia, Russian Interregional Society for the Study of Pain. 2009: 5–21.
5.Expert consensus on reducing the risk of gastrointestinal bleeding in patients receiving oral anticoagulants. Therapy. 2021; 10: 23–41.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
